Medical Foods Market Analysis

  • Report ID: 6298
  • Published Date: Sep 17, 2025
  • Report Format: PDF, PPT

Medical Foods Market Segmentation:

Route of Administration Segment Analysis

Oral segment is poised to hold medical foods market share of over 71.2% by the end of 2035. The demand for medical foods is primarily being driven by initiatives that are supportive, and commercially viable, and the increased preference for orally administered products. Furthermore, many companies such as Nutricia are continuously advancing and modifying their products such as pills, powders, and pre-thickened products according to the market demand. For instance, in January 2023, Nutricia announced its ready-to-drink, plant-based oral nutritional supplement, Fortimel. It is specially formulated with high-quality plant protein from soy and peas sources to meet the nutritional requirements of malnourished people.

Product Segment Analysis

The powder segment in medical foods market is expected to be growing with a staggering size by the end of the forecast period. Most of the medical foods are available in powder form which makes them orally administrable. National Institutes of Health 2020 published a report stating that Souvenaid by Nutricia, a patented medical mix of minerals and vitamins was designed to improve brain functioning in the early stages of Alzheimer’s disease and also supports memory functions.

Moreover, this is useful for the elderly and newborns due to its easy digestion and efficient absorption by the body. Credited to this, many innovations in its formulations are possible to enhance its taste. Powdered medical foods are easier to store and eat because they are dry and have a long shelf life. They are easily found in medical supply stores and can be purchased in plastic or metal containers. In addition to meeting the patient's needs, powdered foods can be made vegan or gluten-free to protect the patient from allergies. This acts as a primary growth factor for this medical foods market expansion.

Our in-depth analysis of the global market includes the following segments:

      Route of Administration

  • Oral

  • Enteral

      Product

  • Powder

  • Pills

  • Liquid

      Application

  • Chronic Kidney Disease

  • Minimal Hepatic Encephalopathy

  • Chemotherapy-induced Diarrhea

  • Pathogen-related Infections

  • Diabetic Neuropathy

  • ADHD

  • Depression

  • Alzheimer's Disease

  • Nutritional Deficiency

  • Wound Healing

  • Chronic Diarrhea

  • Constipation Relief

  • Protein Booster

  • Dysphagia

  • Pain Management

  • Parkinson's Disease

  • Epilepsy

  • Other cancer-related Treatments

  • Severe Protein Allergy

  • Cancer

  • Cachexia

     Sales Channel

  • Online Sales

  • Retail Sales

  • Institutional Sales

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of medical foods is evaluated at USD 26.67 billion.

The global medical foods market size was worth over USD 25.5 billion in 2025 and is poised to grow at a CAGR of over 5.1%, reaching USD 41.93 billion revenue by 2035.

The North America medical foods market will secure over 47% share by 2035, driven by the surge in the geriatric population suffering from chronic conditions.

Key players in the market include Lanfam LLC, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., Fresenius Kabi AG, Mead Johnson & Company, LLC, SFI Health, Danone.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos